ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

St. Baldrick's Launches Giving Tuesday Campaign to Raise $75,000 for Childhood Cancer Research

By: Newsfile

Los Angeles, California--(Newsfile Corp. - December 2, 2025) - This Giving Tuesday the St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants in the U.S., invites communities across the country to join the fight against childhood cancer. With a goal of raising $75,000, the campaign will support pioneering research that gives kids battling cancer a chance at a healthy, hopeful life — because behind every cure is a child's future.

Giving Tuesday, observed annually the Tuesday after Thanksgiving, is a Global Day of Generosity that inspires individuals, organizations, and communities to make an impact. For St. Baldrick's, it is a day to rally support for lifesaving childhood cancer research — work that is critical as 1 in 5 kids diagnosed with cancer in the U.S. will not survive. Donations fund research that leads to safer, more effective treatments, higher survival rates, and improved quality of life for these children and their families.

Your gift this Giving Tuesday is more than a donation — it is a step toward breakthroughs that save lives and protect the futures of kids facing cancer. Every child whose life is saved carries dreams, laughter, and joy into the world, and every parent who witnesses their child survive experiences relief, love, and gratitude that can never be measured.

Thanks to the generosity of the Cetina-Chiu Family, every gift will be matched, up to $25,000, doubling the impact and helping fund research that transforms care and moves us closer to cures.

This year, St. Baldrick's is sharing the courageous stories of the following kids affected by cancer:

Bailey, 3, is facing her diagnosis of ATRT, a type of brain cancer, with courage and a sparkle that lights up every room. As Bailey undergoes a rigorous treatment protocol, every donation helps fuel the research that can give kids like her a chance to grow, discover their passions, and one day change the world.

Claire, 7, was diagnosed with metastatic Ewing sarcoma after a fall led to the discovery of a tumor pressing on her spinal cord. Today, she has completed treatment, is in the 1st grade, and is back to dance and gymnastics — working hard to regain her strength and embodying hope and perseverance.

Immar, 3, was diagnosed with hepatoblastoma in October 2024 after his energy suddenly faded. His treatments were long and harsh, but today he's cancer-free. Kids with cancer like Immar deserve treatments that are easier on their bodies so they can grow up healthy and full of life. Funding research is key to creating safer, more effective therapies a reality.

Wyatt, 6, began treatment for B-cell acute lymphoblastic leukemia in Summer 2024 after his family noticed rapid stomach growth. Despite facing challenging side effects — from high blood pressure to anxiety — Wyatt brings joy, humor, and light into every room he enters, inspiring everyone around him. His story is a powerful reminder that every child deserves to play, laugh, and enjoy the moments that matter — without the burden of illness and treatment.

On Giving Tuesday, December 2, supporters have the chance to be part of a global movement to fund lifesaving childhood cancer research.

Join St. Baldrick's in honoring Bailey, Claire, Immar, Wyatt and the countless kids still fighting cancer. Together, we can fund the research that saves lives and leads to lasting cures.

About St. Baldrick's Foundation
Every 2 minutes, a child somewhere in the world is diagnosed with cancer. In the U.S., 1 in 5 will not survive. The St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants, has awarded more than $369 million to researchers to Conquer Kids' Cancer. When you give to St. Baldrick's, you don't just give to one hospital – you support every institution with the expertise to treat kids with cancer across the U.S. St. Baldrick's ensures that children fighting cancer now — and those diagnosed in the future — will have access to the most cutting-edge treatment, by supporting every stage of research, from new ideas in the lab to the training of the next generation of researchers, to lifesaving clinical trials. St. Baldrick's has played a role in virtually every advancement in the field over the past 25 years and remains essential in advancing progress and fostering innovation in childhood cancer research. Visit StBaldricks.org and help #ConquerKidsCancer.

Media Contact:
Traci Johnson
Traci@stbaldricks.org

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276573

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.15
+0.39 (0.17%)
AAPL  272.56
+0.37 (0.14%)
AMD  209.81
+8.75 (4.35%)
BAC  54.82
+0.56 (1.03%)
GOOG  304.90
+1.15 (0.38%)
META  663.00
-1.45 (-0.22%)
MSFT  486.34
+2.36 (0.49%)
NVDA  179.62
+5.48 (3.14%)
ORCL  194.38
+14.34 (7.97%)
TSLA  484.95
+1.58 (0.33%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.